Deals

TG Therapeutics Raises $18M in Underwritten RDO from J.P. Morgan Global Healthcare Fund

By |

TG Therapeutics, Inc. (TGTX) announced that it has raised $18,135,848 in a Registered Direct transaction. The common stock was sold at $6.71 per share. Ladenburg Thalmann & Co., Inc. acted as Underwriter and Roth Capital Partners, LLC and Brean Capital, LLC acted as Financial Advisors on the transaction. The investor was J.P. Morgan Global Healthcare Fund. Note this Placement is subject to customary closing conditions and is expected to close by 03/17/2014.

Deals

RegeneRx Biopharmaceuticals Raises $2.35M at 37% Discount from Strategic Investor

By |

RegeneRx Biopharmaceuticals, Inc. (RGRX) announced that it has raised $2,350,000 in a Common Stock transaction. The common stock was sold at $0.12 per share, an approximate 37% discount to the market price ($0.19) of RGRX at deal announcement. The investor was Digital Aria Company Limited. The transaction will fund in tranches on 03/28/2014 and 08/31/2014. Concurrently with this Placement the Company entered into two licensing agreements for the license of territorial rights to two of the Company’s Thymosin Beta 4 based products candidates, RGN-259 and RGN-137.

Deals

Euroseas Limited Raises $15M near Market via RMK Maritime

By |

Euroseas Limited (ESEA) announced that it has raised $15,047,200 in a Common Stock transaction. The common stock was sold at $1.34 per share, an approximate 3% discount to the market price ($1.38) of ESEA at deal announcement. RMK Maritime acted as Financial Advisor on the transaction. The transaction is expected to close by 03/14/2014. via PlacementTracker.

Deals

Royal Bancshares of Pennsylvania Raises $5.76M at 60% Discount from Emerald Advisers

By |

Royal Bancshares of Pennsylvania, Inc. (RBPAA) announced that it has raised $5,760,000 in a Common Stock transaction. The common stock was sold at $1.20 per share, an approximate 60% discount to the market price ($3.00) of RBPAA at deal announcement. The investors include Emerald Advisers, Inc. . Issuer counsel was Stevens & Lee. The agreement was reached on March 10, 2014.